COMPANY

Cirrus Therapeutics

Keywords: gene therapy cell therapy ophthalmology AAV dry age-related macular degeneration geographic atrophy age related macular degeneration

Location: Cambridge, MA · source · Oct 15, 2026

Profile checked Oct 10, 2026

Timeline

Oct 2, 2025 Raise Private equity round — Seed: $11M (total, as published), announced Oct 2, 2025. Source: company's own press page. source ↗

Raised: $11.0M. Last 2 years.

Oct 2, 2025 Private equity round — Seed: $11M (total, as published), announced Oct 2, 2025. Source: company's own press page. source ↗